Schedule Dispatches

Schedule dispatches give a summary of changes coming out in the next month.

February 2026

New Listings

• Bisacodyl (Bisacodyl-AFT) tab 5 mg – Only on a prescription (p’code 2720914)
• Calcium polystyrene sulphonate (Roma) powder, 300 g OP – S29 (p’code 2720590)
• Celecoxib (Celostea) cap 200 mg (p’code 2468840)
• Compound electrolytes with glucose [dextrose] (Pedialyte) soln with electrolytes (2 x 500 ml), 1 OP (p’code 2504308)
• Daunorubicin inj 20 mg vial (Cerubidine) (p’code 2720922) and inj 20 mg for ECP, 20 mg OP (Baxter) (p’code 2204193) – PCT only – Specialist
• Enalapril maleate (Ipca-Enalapril) tab 5 mg (p’code 2716771), tab 10 mg (p’code 2716798) and tab 20 mg (p’code 2716801)
• Glycopyrronium bromide (Glycopyrronium-AFT) inj 200 mcg per ml, 1 ml ampoule – Up to 10 inj available on a PSO (p’code 2719258)
• Lenalidomide (Lenalidomide Viatris) cap 15 mg (p’code 2707543) and cap 25 mg (p’code 2707551) – Special Authority – Retail pharmacy
• Losartan potassium with hydrochlorothiazide (I-Losartan & Hydrochlorothiazide – Ipca) tab 50 mg with hydrochlorothiazide 12.5 mg (p’code 2716828)
• Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Molaxole) powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg (p’code 2718332)
• Nifedipine (Valni Retard) tab long-acting 20 mg – s29 and wastage claimable (p’code 2720973)
• Niraparib (Zejula) tab 100 mg, 56 tab – Special Authority – Retail pharmacy and wastage claimable (p’code 2690691)
• Nitisinone (Nitisinone LogixX Pharma) cap 2 mg (p’code 2677687), cap 5 mg (p’code 2677695) and cap 10 mg (p’code 2677709) – Special Authority – Retail pharmacy
• Salbutamol with ipratropium bromide (Cipla) nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 3 ml vial – S29 and wastage claimable (p’code 2719959)

Changes to restrictions, chemical names and presentations

• Adapalene (Differin) gel 0.1%, 30 g OP – amended quantity on prescription
• Adrenaline (Aspen Adrenaline and DBL Adrenaline) inj 1 in 1,000, 1 ml ampoule – addition of note
• Bortezomib inj 3.5 mg vial (DBL Bortezomib) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
• Buprenorphine with naloxone (Buprenorphine Naloxone BNM) tab sublingual 2 mg with naloxone 0.5 mg and tab sublingual 8 mg with naloxone 2 mg – amended Special Authority criteria
• Continuous glucose monitor (interoperable) sensor (9) and transmitter, 1 OP (Dexcom G6), sensor (Dexcom G7 and Freestyle Libre 3 Plus) – amended quantity on prescription
• Continuous glucose monitor (standalone) (Dexcom ONE+, Freestyle Libre 2 Plus and Freestyle Libre 2) sensor – amended quantity on prescription
• Colecalciferol (Vit.D3) cap 1.25 mg (50,000 iu) – amended quantity on prescription
• Covid-19 vaccine – amended eligibility criteria
  • Inj 3 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml multi-dose vial; infant vaccine, yellow cap (Comirnaty (LP.8.1))
  • Inj 10 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, 0.48 ml single-dose vial; paediatric vaccine, light blue cap (Comirnaty (LP.8.1))
  • Inj 30 mcg SARS-CoV-2 spike protein (mRNA) LP.8.1 per 0.3 ml, pre-filled syringe; adult dose (Comirnaty (LP.8.1))
  • Inj 3 mcg bretovameran per 0.3 ml, 0.48 ml vial; infant vaccine, yellow cap (Comirnaty Omicron (JN.1))
  • Inj 10 mcg bretovameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap (Comirnaty Omicron (JN.1))
  • Inj 30 mcg bretovameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap (Comirnaty Omicron (JN.1))
• Dexamfetamine sulfate (Noumed Dexamfetamine) tab 5 mg – amended Special Authority criteria
• Everolimus (Afinitor) tab 5 mg and 10 mg – amended Special Authority criteria
• Hepatitis B recombinant vaccine (Engerix-B) inj 20 mcg per 1 ml prefilled syringe – amended eligibility criteria
• Insulin pen needles 29 g × 12.7 mm, 31 g × 5 mm, 31 g × 8 mm and 32 g × 4 mm (B-D Micro-Fine) and 31 g × 6 mm (Berpu) – amended quantity on prescription
• Insulin pump cartridge (Tandem Cartridge) cartridge 300 u, t:lock × 10, 10 OP – amended quantity on prescription
• Insulin pump infusion set (steel cannula) 6 mm steel needle; 60 cm tubing × 10, 1 OP (MiniMed Sure-T MMT-864A), 6 mm steel needle; 80 cm tubing × 10, 1 OP (MiniMed Sure-T MMT-866A), 8 mm steel needle; 60 cm tubing × 10, 1 OP (MiniMed Sure-T MMT-874A) and 8 mm steel needle; 80 cm tubing × 10, 1 OP (MiniMed Sure-T MMT-876A) – amended quantity on prescription
• Insulin pump infusion set (steel cannula, straight insertion) – amended quantity on prescription
  • 5 mm steel cannula; straight insertion; 45 cm line × 10 with 10 needles, 5.5 mm steel needle; straight insertion; 60 cm line × 10 with 10 needles, 5.5 mm steel needle; straight insertion; 80 cm line × 10 with 10 needles, 8.5 mm steel needle; straight insertion; 60 cm line × 10 with 10 needles and 8.5 mm steel needle; straight insertion; 80 cm line × 10 with 10 needles, 1 OP (mylife Orbit micro)
  • 6 mm steel cannula; straight insertion; 80 cm line × 10 with 10 needles, 8 mm steel cannula; straight insertion; 80 cm line × 10 with 10 needles, 6 mm steel cannula; straight insertion; 60 cm line × 10 with 10 needles and 8 mm steel cannula; straight insertion; 60 cm line × 10 with 10 needles 1 OP (TruSteel)
• Insulin pump infusion set (teflon cannula) – amended quantity on prescription
  • 13 mm teflon needle, 60 cm tubing × 10, 1 OP (MiniMed Silhouette MMT-381A)
  • 17 mm teflon needle, 110 cm tubing × 10, 1 OP (MiniMed Silhouette MMT-377A)
  • 17 mm teflon needle, 60 cm tubing × 10, 1 OP (MiniMed Silhouette MMT-378A)
  • 6 mm teflon needle, 110 cm tubing × 10, 1 OP (MiniMed Quick-Set MMT-398A)
  • 6 mm teflon needle, 60 cm tubing × 10, 1 OP (MiniMed Quick-Set MMT-399A)
  • 9 mm teflon needle, 110 cm tubing × 10, 1 OP (MiniMed Quick-Set MMT-396A)
  • 9 mm teflon needle, 60 cm tubing × 10, 1 OP (MiniMed Quick-Set MMT-397A)
• Insulin pump infusion set (teflon cannula, angle insertion with insertion device) – amended quantity on prescription
  • 6 mm teflon cannula; angle insertion; insertion device; 60 cm line × 4 with 4 needles, 1 OP (Med Adv Ext Infusion Set MDT-MMT-431AK) – amended brand name
  • 6 mm teflon cannula; angle insertion; insertion device; 80 cm line × 4 with 4 needles, 1 OP (Med Adv Ext Infusion Set MDT-MMT-432AK) – amended brand name
  • 9 mm teflon cannula; angle insertion; insertion device; 60 cm line × 4 with 4 needles, 1 OP (Med Adv Ext Infusion Set MDT-MMT-441AK) – amended brand name
  • 9 mm teflon cannula; angle insertion; insertion device; 80 cm line × 4 with 4 needles, 1 OP (Med Adv Ext Infusion Set MDT-MMT-442AK) – amended brand name
  • 13 mm teflon cannula; angle insertion; insertion device; 110 cm line × 10 with 10 needles, 1 OP (AutoSoft 30)
  • 13 mm teflon cannula; angle insertion; insertion device; 60 cm line × 10 with 10 needles , 1 OP (AutoSoft 30)
• Insulin pump infusion set (teflon cannula, flexible insertion with insertion device) (mylife Inset soft) 6 mm teflon cannula; flexible insertion; insertion device; 46 cm line × 10 with 10 needles, 6 mm teflon cannula; flexible insertion; insertion device; 60 cm line with integrated inserter × 10 with 10 needles, 6 mm teflon cannula; flexible insertion; insertion device; 80 cm line × 10 with 10 needles, 9 mm teflon cannula; flexible insertion; insertion device; 60 cm line × 10 with 10 needles and 9 mm teflon cannula; flexible insertion; insertion device; 80 cm line × 10 with 10 needles, 1 OP – amended quantity on prescription
• Insulin pump infusion set (teflon cannula, straight insertion with insertion device) (AutoSoft 90) 6 mm teflon cannula; straight insertion; insertion device; 110 cm line × 10 with 10 needles, 6 mm teflon cannula; straight insertion; insertion device; 60 cm line × 10 with 10 needles, 9 mm teflon cannula; straight insertion; insertion device; 110 cm line × 10 with 10 needles and 9 mm teflon cannula; straight insertion; insertion device; 60 cm line × 10 with 10 needles, 1 OP – amended quantity on prescription
• Insulin pump infusion set (teflon cannula, variable insertion) (VariSoft) 13 mm teflon cannula; variable insertion; 60 cm line × 10 with 10 needles, 1 OP – amended quantity on prescription
• Insulin pump reservoir – amended quantity on prescription
  • 10 × 1.6 ml glass reservoir for YpsoPump, 10 OP (mylife YpsoPump Reservoir)
  • 10 × luer lock conversion cartridges 1.8 ml for paradigm pumps, 10 OP (ADR Cartridge 1.8)
  • Cartridge for 7 series pump; 3.0 ml × 10, 10 OP (MiniMed 3.0 Reservoir MMT-332A)
  • Cartridge for 7 series pump; 3.0 ml × 5, 5 OP (MiniMed 3.0 Ext Reservoir MDT-MMT-342G)
• Insulin syringes, disposable with attached needle (B-D Ultra Fine and B-D Ultra Fine II) syringe 0.3 ml with 29 g × 12.7 mm needle, syringe 0.3 ml with 31 g × 8 mm needle, syringe 0.5 ml with 29 g × 12.7 mm needle, syringe 0.5 ml with 31 g × 8 mm needle, syringe 1 ml with 29 g × 12.7 mm needle and syringe 1 ml with 31 g × 8 mm needle – amended quantity on prescription
• Isotretinoin (Oratane) cap 5 mg, 10 mg and 20 mg – amended Special Authority criteria
• Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen – amended note and quantity on prescription
• Lisdexamfetamine dimesilate (Vyvanse) cap 30 mg, 50 mg and 70 mg – amended Special Authority criteria
• Methotrexate tab 2.5 mg and 10 mg (Trexate), inj 2.5 mg per ml, 2 ml (Methotrexate DBL), inj 25 mg per ml, 2 ml vial (Methotrexate DBL Onco-Vial), inj 25 mg per ml, 20 ml vial (DBL Methotrexate Onco-Vial) and inj 100 mg per ml, 10 ml and 50 ml vial (Methotrexate Ebewe) – removal of Retail pharmacy-Specialist rule
• Methylphenidate hydrochloride – amended Special Authority criteria
  • Tab modified-release 18 mg, 27 mg, 36 mg and 54 mg (Methylphenidate Sandoz XR)
  • Tab immediate-release 5 mg, 10 mg and 20 mg (Rubifen)
  • Tab immediate-release 10 mg (Ritalin)
  • Tab sustained-release 20 mg (Ribifen SR)
  • Tab extended-release 18 mg, 27 mg, 36 mg and 54 mg (Methylphenidate ER – Teva)
• Methylphenidate hydrochloride extended-release tab extended-release 18 mg, 27 mg, 36 mg and 54 mg (Concerta) and cap modified-release 10 mg, 20 mg, 30 mg and 40 mg (Ritalin LA) – amended Special Authority criteria
• Nortriptyline hydrochloride (Allegron and Norpress) tab 10 mg and 25 mg – removal of brand switch fee
• Olanzapine (Zyprexa Relprevv) inj 210 mg, 300 mg and 405 mg vial – amended Special Authority criteria and removal of note
• Omalizumab inj 150 mg prefilled syringe (Xolair and Xolair AU) and inj 150 mg vial (Xolair) – amended Special Authority criteria
• Pazopanib (Pazopanib Teva) tab 200 mg and 400 mg – amended Special Authority criteria
• Temozolomide cap 5 mg, 20 mg, 100 mg, 140 mg and 250 mg (Temaccord), cap 5 mg (Temozolomide-Taro) and cap 20 mg and 100 mg (Apo-Temozolomide) – amended Special Authority criteria
• Tretinoin (ReTrieve) crm 0.5 mg per g, 50 g OP – amended quantity on prescription
• Upadacitinib (Rinvoq) tab modified-release 15 mg, 30 mg and 45 mg – amended Special Authority criteria
• Venetoclax (Venclexta) tab 14 × 10 mg, 7 × 50 mg, 21 × 100 mg; 42 OP, tab 10 mg, 2 OP; tab 50 mg, 7 OP; and tab 100 mg – amended Special Authority criteria

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Clotrimazole	Crm 1%, 20 g OP Vaginal crm 1% with applicators, 35 g OP Vaginal crm 2% with applicators, 20 g OP	Clomazol
Morphine sulphate	Cap long-acting 10 mg, 30 mg, 60 mg and 100 mg	m-Eslon
Pegylated interferon alfa-2a	Inj 180 mcg prefilled syringe	Pegasys

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Hydrocortisone	Crm 1%, 30 g OP	Ethics
Lidocaine [lignocaine] hydrochloride	Oral (gel) soln 2%, 200 ml	Mucosoothe
Paracetamol	Oral liq 250 mg per 5 ml, 200 ml	Pamol
Vinorelbine	Inj 1 mg for ECP	Baxter